Creative Medical Technology (CELZ) announced mid-term follow-up data from its StemSpine pilot study utilizing its AlloStem cells for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback